Ensign Peak Advisors, Inc
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$473,052
+$11,875 QoQ
Shares Held
881
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#256
of 411 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. MDGL ranks #86 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in MDGL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $473,052 | 881 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $461,177 | 881 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $29,705,163 | 51,010 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $24,431,442 | 53,267 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $14,647,473 | 48,399 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,031,200 | 48,399 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,911,343 | 35,361 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,339,069 | 15,734 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,357,779 | 83,373 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $24,625,894 | 92,218 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,209,508 | 61,412 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,454,903 | 51,047 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,516,507 | 41,197 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,729,013 | 27,776 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $297,654 | 4,580 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $936,839 | 13,088 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $153,067 | 1,560 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $132,194 | 1,560 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||